ReviewPharmaceutical research2026

Recent Progress in Exosome-Derived Nanocarriers for Breast Cancer Therapy: Advances, Translational Barriers, and Scale-Up Considerations.

Julie R Youssef et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.